FDA product code · Neurology · Class 2
HAW: Neurological Stereotaxic Instrument
HAW is FDA's product code for "Neurological Stereotaxic Instrument": a Class 2 device classified under 21 CFR 882.4560, reviewed by the Neurology panel.
510(k) review time for HAW
Across 71 510(k) clearances under HAW decided from 2018-01-01 to 2026-10-06, the median was 138 days from FDA receipt to decision. Half took between 89 and 226 days, and 80% were decided within 260 days. These are past clearances, not a forecast for a new submission.
| Fastest | 28 |
|---|---|
| 25th percentile | 89 |
| Median | 138 |
| 75th percentile | 226 |
| 80th percentile | 260 |
| 90th percentile | 296 |
| Slowest | 846 |
| Year | Median days | n |
|---|---|---|
| 2018 | 112 | 6 |
| 2019 | 147 | 10 |
| 2020 | 88 | 5 |
| 2021 | 168 | 9 |
| 2022 | 128 | 7 |
| 2023 | 142 | 14 |
| 2024 | 107 | 7 |
| 2025 | 163 | 9 |
Source: openFDA 510(k) records, snapshot of 2026-10-06 (openFDA data as of 2026-09-28). Compare 510(k) review times across all device types, see every code side by side in the Clearance Timeline Estimator, or browse the clearances themselves in PredicateScope.
HAW in the public FDA record
| 510(k) clearances, all years | 424 |
|---|---|
| Device recalls | 197 |
| Establishment listings | 720 |
| GUDID device identifiers | 5,249 |
Counts of records, not of devices or events. Adverse event reports for HAW are in MAUDEScope, as counts with the query shown: MAUDE has no denominator, so a report count is not a rate and does not show that a device caused an event.
FDA-recognized standards that cite HAW
No FDA recognized consensus standard cites HAW by product code. Horizontal standards such as biocompatibility, sterilization and software standards can still apply.
Source: FDA Recognized Consensus Standards, snapshot of 2026-09-01. Search them all in the Consensus Standards Lookup.